We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.03M
2
SNAP icon
Snap
SNAP
+$4.75M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.11M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.09M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.03M

Top Sells

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$15.8M
2
NVDA icon
NVIDIA
NVDA
+$3.72M
3
COIN icon
Coinbase
COIN
+$2.93M
4
AVGO icon
Broadcom
AVGO
+$2.69M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVST icon
2051
Envista
NVST
$4.52B
$3.48K ﹤0.01%
163
+114
+233% +$2.58K
OTTR icon
2052
Otter Tail
OTTR
$3.94B
$3.46K ﹤0.01%
40
– –
DNOW icon
2053
DNOW Inc
DNOW
$2.99B
$3.45K ﹤0.01%
227
– –
AZTA icon
2054
Azenta
AZTA
$1.48B
$3.44K ﹤0.01%
57
– –
CERT icon
2055
Certara
CERT
$1.25B
$3.43K ﹤0.01%
192
– –
MRUS
2056
DELISTED
Merus
MRUS
$3.42K ﹤0.01%
76
– –
TARS icon
2057
Tarsus Pharmaceuticals
TARS
$2.84B
$3.42K ﹤0.01%
94
– –
SGI
2058
Somnigroup International
SGI
$13.7B
$3.41K ﹤0.01%
60
– –
MHO icon
2059
M/I Homes
MHO
$3.84B
$3.41K ﹤0.01%
25
+1
+4% +$127
BXC icon
2060
BlueLinx
BXC
$706M
$3.39K ﹤0.01%
26
– –
AORT icon
2061
Artivion
AORT
$1.32B
$3.36K ﹤0.01%
159
+3
+2% +$56
TVTX icon
2062
Travere Therapeutics
TVTX
$5.78B
$3.36K ﹤0.01%
+436
New +$3.68K
MTLS
2063
Materialise
MTLS
$396M
$3.35K ﹤0.01%
634
+72
+13% +$404
ZYME icon
2064
Zymeworks
ZYME
$1.67B
$3.35K ﹤0.01%
318
– –
GRC icon
2065
Gorman-Rupp
GRC
$2.21B
$3.32K ﹤0.01%
84
– –
ALNT icon
2066
Allient
ALNT
$1.92B
$3.32K ﹤0.01%
93
– –
RYZ
2067
Ryerson Holding Corp
RYZ
$1.46B
$3.32K ﹤0.01%
99
– –
CLDT
2068
Chatham Lodging
CLDT
$586M
$3.32K ﹤0.01%
328
– –
VVX icon
2069
V2X
VVX
$2.65B
$3.32K ﹤0.01%
71
-41
-37% -$1.68K
SGRY icon
2070
Surgery Partners
SGRY
$2.03B
$3.28K ﹤0.01%
110
+7
+7% +$219
VRDN icon
2071
Viridian Therapeutics
VRDN
$2.67B
$3.27K ﹤0.01%
187
– –
MORF
2072
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.24K ﹤0.01%
92
– –
CFLT
2073
DELISTED
Confluent
CFLT
$3.23K ﹤0.01%
+106
New +$2.99K
SIG icon
2074
Signet Jewelers
SIG
$3.76B
$3.2K ﹤0.01%
32
– –
AIZ icon
2075
Assurant
AIZ
$14.3B
$3.2K ﹤0.01%
17
– –
81 82
83
84 85

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.